FR2135270A1 - Prostaglandin analogues - showing prolonged specific activity - Google Patents
Prostaglandin analogues - showing prolonged specific activityInfo
- Publication number
- FR2135270A1 FR2135270A1 FR7215747A FR7215747A FR2135270A1 FR 2135270 A1 FR2135270 A1 FR 2135270A1 FR 7215747 A FR7215747 A FR 7215747A FR 7215747 A FR7215747 A FR 7215747A FR 2135270 A1 FR2135270 A1 FR 2135270A1
- Authority
- FR
- France
- Prior art keywords
- specific activity
- prostaglandin analogues
- showing prolonged
- prolonged specific
- showing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940006138 antiglaucoma drug and miotics prostaglandin analogues Drugs 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 230000002035 prolonged effect Effects 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001768 cations Chemical class 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P31/00—Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14025171A | 1971-05-04 | 1971-05-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2135270A1 true FR2135270A1 (en) | 1972-12-15 |
| FR2135270B1 FR2135270B1 (https=) | 1976-05-14 |
Family
ID=22490405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7215747A Granted FR2135270A1 (en) | 1971-05-04 | 1972-05-03 | Prostaglandin analogues - showing prolonged specific activity |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE783028A (https=) |
| CA (1) | CA963900A (https=) |
| CH (2) | CH566284A5 (https=) |
| DE (1) | DE2221443A1 (https=) |
| FR (1) | FR2135270A1 (https=) |
| HU (1) | HU166654B (https=) |
| NL (1) | NL7205997A (https=) |
| PL (1) | PL88998B1 (https=) |
| SE (1) | SE401921B (https=) |
| ZA (1) | ZA722435B (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2199983A1 (https=) * | 1972-09-15 | 1974-04-19 | Upjohn Co |
-
1972
- 1972-04-11 CA CA139,418A patent/CA963900A/en not_active Expired
- 1972-04-11 ZA ZA722435A patent/ZA722435B/xx unknown
- 1972-04-27 CH CH437675A patent/CH566284A5/xx not_active IP Right Cessation
- 1972-04-27 CH CH628172A patent/CH566283A5/xx not_active IP Right Cessation
- 1972-05-02 DE DE19722221443 patent/DE2221443A1/de not_active Withdrawn
- 1972-05-02 PL PL1972155108A patent/PL88998B1/pl unknown
- 1972-05-03 FR FR7215747A patent/FR2135270A1/fr active Granted
- 1972-05-04 HU HUUO76A patent/HU166654B/hu unknown
- 1972-05-04 BE BE783028A patent/BE783028A/xx not_active IP Right Cessation
- 1972-05-04 NL NL7205997A patent/NL7205997A/xx not_active Application Discontinuation
-
1975
- 1975-07-08 SE SE7507801A patent/SE401921B/xx unknown
Non-Patent Citations (1)
| Title |
|---|
| NEANT * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2199983A1 (https=) * | 1972-09-15 | 1974-04-19 | Upjohn Co |
Also Published As
| Publication number | Publication date |
|---|---|
| PL88998B1 (en) | 1976-10-30 |
| SE401921B (sv) | 1978-06-05 |
| CA963900A (en) | 1975-03-04 |
| CH566283A5 (https=) | 1975-09-15 |
| HU166654B (https=) | 1975-04-28 |
| NL7205997A (https=) | 1972-11-07 |
| CH566284A5 (https=) | 1975-09-15 |
| SE7507801L (sv) | 1975-07-08 |
| BE783028A (fr) | 1972-11-06 |
| ZA722435B (en) | 1973-02-28 |
| DE2221443A1 (de) | 1972-11-16 |
| AU4154572A (en) | 1973-11-01 |
| FR2135270B1 (https=) | 1976-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1422518A (en) | 11-deoxyprostaglandin derivatives and process therefor | |
| ES418924A1 (es) | Procedimiento para la obtencion de 13, 14-dihidroprosta- glandinas. | |
| GB1451569A (en) | 2,7,10,15,18,23-hexamethyltetracosane and process for preparing it | |
| GB1515012A (en) | Bisulphite terminated oligomers | |
| FR2135270A1 (en) | Prostaglandin analogues - showing prolonged specific activity | |
| GB1506823A (en) | Prostaglandins | |
| GB1337467A (en) | Wetting compositions and treatment of surfaces therewith | |
| GB1497550A (en) | 5,6-epoxybicyclo(2,2,2)octanes | |
| GB1299136A (en) | Improvements in or relating to prostaglandins and the preparation thereof | |
| SE7504150L (sv) | Prostaglandin kompositioner | |
| GB1478587A (en) | Preparation of alpha-6-deoxy-5-hydroxytetracycline | |
| GB1352793A (en) | Detergent composition | |
| FR2243653A1 (en) | Incorporation of alkali metal chlorides in media - with oil-based preservative | |
| ES422831A1 (es) | Procedimiento para la obtencion de derivados de ciclopenta-no. | |
| GB1405638A (en) | Combatting the growth of unwanted plants | |
| ES462887A1 (es) | Procedimiento para la preparacion de nuevos derivados de la 9-cloroprednisolana. | |
| JPS5214588A (en) | Brake fluid composition | |
| GB1328706A (en) | 2,6-dialkyl-3-hydroxy-6-beta-carboxyethyl-caclohex-2-en-1-ones | |
| ES8603399A1 (es) | Un procedimiento para sintetizar compuestos analogos de 13,14-dideshidro-15-oxo de la serie e de prostaglandinas | |
| ES438238A1 (es) | Un procedimiento para producir prostaglandinas racemicas (dl)-13-sulfinil sustituidas. | |
| GB1535994A (en) | Deuterated prostaglandin analogues | |
| FR2047641A5 (en) | 5-(1-alkenyl)-2-norbornene by isomerisation - of 5-(2'-alkenyl)-2-norbornene | |
| FR2085552A1 (en) | Oxadiazine-4-thiones in vulcanizable rubber - compositions | |
| ES394667A1 (es) | Procedimiento de preparacion de derivados del acido prosta-noico. | |
| CA968792A (en) | Stereospecific reduction of 9,15-diketo prostaglandins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |